Non-Alcoholic Steatohepatitis Treatment Market Set for 28.0% CAGR Growth, Projected to Hit $90.97 Billion by 2034 |PMR New York, USA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Market Statistics The global non-alcoholic steatohepatitis treatment market size was USD 7.70 billion in 2024, estimated at USD 9.85 billion in...

Challenges in Non-Alcoholic Steatohepatitis (NASH) Diagnosis and Lack of Definitive Methods Hamper Market Growth Despite Rising Awareness Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential...

Global Non-Alcoholic Steatohepatitis Market Report to 2027 - Featuring Intercept Pharmaceuticals, Novartis, Siemens Healthineers and AstraZeneca Among Others Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of...

Worldwide Non-Alcoholic Steatohepatitis Treatment Industry to 2030 - Featuring AstraZeneca, Conatus Pharmaceuticals, Enzo Biochem and GENFIT Among Others Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022...